Spj Onco Care Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 16-11-2024
- Paid Up Capital ₹ 5.22 M
as on 16-11-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.16 Cr
as on 16-11-2024
- Revenue 41.00%
(FY 2023)
- Profit -0.59%
(FY 2023)
- Ebitda -20.99%
(FY 2023)
- Net Worth -18.80%
(FY 2023)
- Total Assets -19.00%
(FY 2023)
About Spj Onco Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 5.22 M.
The company currently has active open charges totaling ₹1.16 Cr.
Sanket Mehta, Nilesh Chordiya, Praveen Kammar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC317531
- Company No.
317531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Spj Onco Care?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Kammar  | Director | 28-Nov-2018 | Current |
| Nilesh Chordiya | Director | 01-Mar-2021 | Current |
| Amit Chakraborty | Director | 05-Mar-2021 | Current |
| Sanket Mehta | Director | 28-Nov-2018 | Current |
| Jay Anam | Director | 28-Nov-2018 | Current |
| Chetan Anchan | Director | 16-Mar-2020 | Current |
Financial Performance of Spj Onco Care.
Spj Onco Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41% increase. The company also saw a slight decrease in profitability, with a 0.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spj Onco Care?
In 2023, Spj Onco Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pred Healthcare Solutions LlpActive 3 years 5 monthsSanket Mehta, Nilesh Chordiya and 4 more are mutual person
- Specialty Surgical Oncology LlpActive 3 years 4 months
Sanket Mehta, Nilesh Chordiya and 4 more are mutual person
- Cytocure Medicare Private LimitedActive 6 years 3 days
Sanket Mehta, Nilesh Chordiya and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jan 2020 | ₹1.16 Cr | Open |
How Many Employees Work at Spj Onco Care?
Unlock and access historical data on people associated with Spj Onco Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spj Onco Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spj Onco Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
